Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

Intuitive Surgical

Medtronic

As the population of our country continues to age, treatments and disease detection will continue to increase in demand. Additionally, improvements in imaging, robotics, and AI technology continue to give scientists new tools to make better medical devices.

3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth

VAREX IMAGING (VREX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About VAREX IMAGING (VREX) Rating Upgrade to Buy

Boston Scientific

VREX vs. BSX: Which Stock Is the Better Value Option?

VREX or BSX: Which Is the Better Value Stock Right Now?

Varex Imaging Corporation (NASDAQ:VREX ) Q1 2023 Earnings Conference Call January 31, 2023 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Young Li - Jefferies Larry Solow - CJS Securities Suraj Kalia - Oppenheimer Anthony Petrone - Mizuho Group Jim Sidoti - Sidoti & Company Operator Greetings and welcome to the Varex First Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in listen-only mode.

Varex Imaging Corporation (VREX) Q1 2023 Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -27.27% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Misses Q1 Earnings Estimates

SALT LAKE CITY--( BUSINESS WIRE )--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2023.

Varex Announces Financial Results for First Quarter Fiscal Year 2023

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing VAREX IMAGING (VREX) Right Now?

LeMaitre Vascular

VREX vs. LMAT: Which Stock Is the Better Value Option?

SALT LAKE CITY--( BUSINESS WIRE )--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2023 following the close of regular trading on Tuesday, January 31, 2023. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.

Varex Schedules First Quarter Fiscal Year 2023 Earnings Release and Conference Call

SALT LAKE CITY--( BUSINESS WIRE )--Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to present at CJS Securities 23rd Annual New Ideas for the New Year virtual investor conferences. Details are as follows:

Varex to Present at CJS Securities 23rd Annual New Ideas for the New Year Virtual Investor Conference

Varex Imaging Corporation (NASDAQ:VREX ) Q4 2022 Earnings Conference Call November 15, 2022 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President & Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Larry Solow - CJS Suraj Kalia - Oppenheimer Anthony Petrone - Mizuho Group Jim Sidoti - Sidoti & Company Operator Hello and welcome to the Varex Fourth Quarter Fiscal Year 2022 Earnings Call. At this time, all participants are in listen-only mode.

Varex Imaging Corporation (VREX) Q4 2022 Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 52.38% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Surpasses Q4 Earnings and Revenue Estimates

SALT LAKE CITY--( BUSINESS WIRE )--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2022.

Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2022

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate VAREX IMAGING (VREX) to Report a Decline in Earnings: What to Look Out for

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2022 following the close of regular trading on Tuesday, November 15, 2022.

Varex Schedules Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call

OrthoPediatrics

Malibu Boats

Photronics

Douglas Dynamics

Stratasys

Generally speaking, you want to keep your portfolio tied largely to blue-chip stocks.  However, on occasion, your portfolio should also include cheap small-cap stocks.

7 Small-Cap Stocks That Are Too Cheap to Ignore

Varex Imaging Corporation (NASDAQ:VREX ) Q3 2022 Results Conference Call August 2, 2022 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Shubham Maheshwari - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities James Sidoti - Sidoiti & Company Suraj Kalia - Oppenheimer& Co Operator Greetings. Welcome to the Varex Third Quarter Fiscal Year 2022 Earnings Call.

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q3 2022 Results - Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (“Varex”) (Nasdaq: VREX) today announced that Kathleen L. Bardwell has been appointed to the company's Board of Directors, effective July 29, 2022. Ms. Bardwell is the former Senior Vice President, Regulatory Affairs & Compliance for STERIS Corporation, a leading provider of infection prevention and other procedural products and services. Prior to serving in this role, she served from March 2008 to November 2019 as Senior Vice Presi

Varex Names Kathleen L. Bardwell to Board of Directors

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2022. 3QFY22 Summary Revenues $214 million GAAP gross margin 34% | Non-GAAP gross margin* 35% GAAP operating expense $50 million | Non-GAAP operating expense* $47 million GAAP operating margin 11% | Non-GAAP operating margin* 13% GAAP net earnings $0.20 per diluted share | Non-GAAP net earnings* $0.37 per diluted share “Our supply chain d

Varex Announces Financial Results for Third Quarter Fiscal Year 2022

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2022 following the close of regular trading on Tuesday, August 2, 2022. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at vareximaging.com/news. Investors can also access this conference call at 8

Varex Schedules Third Quarter Fiscal Year 2022 Earnings Release and Conference Call

Varex Imaging Corporation (NASDAQ:VREX ) Q2 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President & Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Suraj Kalia - Oppenheimer Jim Sidoti - Sidoti & Company Operator Greetings. Welcome to the Varex Second Quarter Fiscal Year 2022 Earnings Call.

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q2 2022 Results - Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2022. 2QFY22 Summary Revenues $215 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating expense $44 million | Non-GAAP operating expense* $41 million GAAP operating margin 12% | Non-GAAP operating margin* 15% GAAP net earnings $0.18 per diluted share | Non-GAAP net earnings* $0.37 per diluted share “We continued to s

Varex Announces Financial Results for Second Quarter Fiscal Year 2022

SALT LAKE CITY--(BUSINESS WIRE)--Varex Schedules Second Quarter Fiscal Year 2022 Earnings Release and Conference Call

Varex Schedules Second Quarter Fiscal Year 2022 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--VAREX TO PRESENT AT OPPENHEIMER'S 32ND ANNUAL HEALTHCARE VIRTUAL INVESTOR CONFERENCE

Varex to Present at Oppenheimer's 32nd Annual Healthcare Virtual Investor Conference

SALT LAKE CITY--(BUSINESS WIRE)--Varex Announces Partial Redemption of Senior Secured Notes

News for Varex Imaging Stock (VREX)